AKESOgen Ranks as the No. 33 Healthcare Company and 448th Overall on the 2017 Inc.500
NEW YORK and ATLANTA August 16, 2017 – Inc. magazine today ranked AKESOgen, 33rd as a Healthcare company and 448th overall on its 36th annual Inc. 500, the most prestigious ranking of the nation’s fastest-growing private companies. The list represents a unique look at the most successful companies within the American economy’s most dynamic segment— its independent small businesses. Companies such as Microsoft, Dell, Domino’s Pizza, Pandora, Timberland, LinkedIn, Yelp, Zillow, and many other well-known names gained their first national exposure as honorees of the Inc. 500|5000.
“For the third consecutive year, we are delighted to be recognized as an Inc.500 honoree, sharing a pedigree with Intuit, Zappos, Under Armour, GoPro, Timberland, Clif Bar, Patagonia, Oracle, Box, Grubhub, and dozens of other Inc.500 alumni that have gone on to be household names.” commented AKESOgen CEO Robert Boisjoli.
“Understanding your own genetic make up and what your DNA says about you is becoming more and more a part of our everyday lives and will only continue to increase – especially with new technologies which make this information more and more accessible to the public. We are fortunate to be front and center in this new wave of emerging precision medicine molecular capabilities which are rapidly becoming mainstrain in our society.” says Mark Bouzyk, PhD, AKESOgen’s Chief Scientific Officer.
The 2017 Inc. 5000, unveiled online at Inc.com and with the top 500 companies featured in the September issue of Inc. is the most competitive crop in the list’s history. The average company on the list achieved a mind-boggling three-year average growth of 481%. The Inc. 5000’s aggregate revenue is $206 billion, and the companies on the list collectively generated 619,500 jobs over the past three years. Complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, can be found at www.inc.com/inc5000.
“The Inc. 5000 is the most persuasive evidence I know that the American Dream is still alive,” says Inc. President and Editor-In-Chief Eric Schurenberg. “The founders and CEOs of the Inc. 5000 tell us they think determination, risk taking, and vision were the keys to their success, and I believe them.”
About Inc. Media:
Founded in 1979 and acquired in 2005 by Mansueto Ventures, Inc. is the only major brand dedicated exclusively to owners and managers of growing private companies, with the aim to deliver real solutions for today’s innovative company builders. Winner of the National Magazine Award for General Excellence in both 2014 and 2012. Total monthly audience reach for the brand has grown significantly from 2,000,000 in 2010 to over 18,000,000 today. For more information, visit www.inc.com.
For more information contact:
About AKESOgen, Inc.
AKESOgen is an integrated Clinical Laboratory Improvement Amendments (CLIA) compliant and College of American Pathology (CAP) accredited genomics, genetics and bio-banking company that services the pharmaceutical, biotechnology, clinical, academic, and government sectors for clinical trials, diagnostic clinical testing, and research. Based in Atlanta, GA, USA, the company’s main focus is oncology, neurology and personalized medicine. AKESOgen’s services include providing high-throughput, biomarker profiling, cytogenetic arrays, sequencing, and genomics analysis utilizing different types of markers (e.g. DNA, mRNA, miRNA, and methylation). For more information, visit www.akesogen.com.
Marissa Cooke, Director, Business Development and Marketing, AKESOgen, Inc. +1 770-542-0890, or firstname.lastname@example.org